Novo Nordisk · 1 week ago
Associate Business Finance Partner - API
Clayton, NC
Full-time
Onsite
Entry, Mid Level
2+ years expNovo Nordisk is a leader in diabetes care, striving to improve the quality of life for millions globally. The Associate Business Finance Partner will act as a finance partner to stakeholders, using data and business knowledge to create insights for decision-making and ensure financial control at the facility.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Use process area knowledge & business insights to seek improvement opportunities & solve business challenges
Proactively support central or local business cases & decision-making involving areas of process responsibility
Ensure increase of financial understanding across the organization by offering training & participating in cross area processes, site visits, etc
Drive timely & solid delivery of formal submissions & ad-hoc requests within area of expertise
Ensure that financial deliverables from the site are aligned to requirements from HQ Finance
Safeguard that the site process areas meet financial targets by using continuous analysis, follow-up & suggesting corrective/preventive actions to production responsible, Directors & CVP
Represent site in financial matters as needed, including central forums & work groups
Areas of responsibility may include ensuring adherence to internal and external accounting guidelines to maintain financial compliance and integrity, managing project portfolios and assets including investment budgets and reviews, developing and enhancing business intelligence tools, overseeing manning and capacity costs through site-wide budgeting processes, and driving planning, forecasting, and financial controlling activities
Follow all safety & environmental requirements in the performance of duties
Other accountabilities, as assigned
Qualification
Required
Bachelor's Degree in Business, Finance, or related field of study from an accredited university required and a minimum of two (2) years of financial analytical and financial accounting experience required
In lieu of BS Degree & two (2) years of financial analytical and financial accounting experience, may consider an Associate Degree in Business, Finance, or related field of study from an accredited college or university with a minimum of four (4) years of financial analytical and financial accounting experience required
Able to develop & manage action plans to achieve targets required
Preferred
MBA in finance, accounting, economics or related field preferred
Experience in manufacturing, maintenance or process with a preference toward pharmaceutical or other regulated industries preferred
Experience with project management and project financials preferred
Demonstrated knowledge of the SAP system preferred
Advanced knowledge within corporate finance systems, preferably within pharmaceutical industries preferred
Benefits
Leading pay and annual performance bonus for all positions
Generous paid time off including 14 paid holidays
Health Insurance, Dental Insurance, Vision Insurance – effective day one
Guaranteed 8% 401K contribution plus individual company match option
Family Focused Benefits including 14 weeks paid parental & 6 weeks paid family medical leave
Free access to Novo Nordisk-marketed pharmaceutical products
Tuition Assistance
Life & Disability Insurance
Employee Referral Awards
Company
Novo Nordisk
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.
10001+ employees
H1B Sponsorship
Novo Nordisk has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (25)
2024 (21)
2023 (13)
2022 (10)
2021 (9)
2020 (12)
Funding
Current Stage
Public CompanyTotal Funding
$22M2018-12-05Post Ipo Equity· $22M
1981-07-09IPO
Leadership Team
Lars Fruergaard Jørgensen
President and CEO
Lars Sorensen
President & CEO
Recent News
2026-01-08
2026-01-07
Company data provided by crunchbase